Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial) (Sep, 10.1007/s00432-020-03327-2, 2020)

Wiegel Thomas; Albers Peter; Bartkowiak Detlef; Bussar-Maatz Roswitha; Haerter Martin; Kristiansen Glen; Martus Peter; Wellek Stefan; Schmidberger Heinz; Grozinger Klaus; Renner Peter; Schneider Fried; Burmester Martin; Stockle Michael

首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial) (Sep, 10.1007/s00432-020-03327-2, 2020)

【24h】

Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial) (Sep, 10.1007/s00432-020-03327-2, 2020)

机译：低或早期风险前列腺癌（Prefere试验）患者治疗方式的随机试验结果（Prefere试验）（90.1007 / S00432-020-03327-2,2020）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The above mentioned corrections will not change the interpretation or conclusions.

机译：上述更正不会改变解释或结论。

著录项

来源
《Journal of Cancer Research and Clinical Oncology 》 |2021年第1期| 共2页
作者
Wiegel Thomas; Albers Peter; Bartkowiak Detlef; Bussar-Maatz Roswitha; Haerter Martin; Kristiansen Glen; Martus Peter; Wellek Stefan; Schmidberger Heinz; Grozinger Klaus; Renner Peter; Schneider Fried; Burmester Martin; Stockle Michael;
展开▼
作者单位

Univ Hosp Ulm Dept Radiotherapy &

Radiat Oncol Albert Einstein Allee 23 D-89081 Ulm Germany;

Univ Hosp Dusseldorf Dept Urol Dusseldorf Germany;

Univ Hosp Ulm Dept Radiotherapy &

Radiat Oncol Albert Einstein Allee 23 D-89081 Ulm Germany;

German Canc Soc PREFERE Project Management Berlin Germany;

Univ Med Ctr Hamburg Eppendorf Dept Med Psychol Hamburg Germany;

Univ Hosp Bonn Inst Pathol Bonn Germany;

Univ Hosp Tubingen Dept Clin Epidemiol &

Appl Biostat Tubingen Germany;

Johannes Gutenberg Univ Mainz Dept Med Biostat Epidemiol &

Informat Mainz Germany;

Univ Hosp Mainz Dept Radiotherapy &

Radiat Oncol Mainz Germany;

Klinikum Leverkusen Dept Urol Leverkusen Germany;

Ctr Urol Lubeck Germany;

Klinikum Lippe Detmold Dept Urol Detmold Germany;

Vinzenzkrankenhaus Dept Urol Hannover Germany;

Univ Hosp Homburg Saar Dept Urol Homburg Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort [J] . Yao Zhu, Ding-Wei Ye, Jin-You Wang, 亚洲男性学杂志（英文版） . 2012 ,第005期
2. Effects of Exercise on Cancer-related Fatigue and Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Meta-analysis of Randomized Clinical Trials [J] . Bo Yang, Jiansheng Wang 中国医学科学杂志（英文版） . 2017 ,第001期
3. Intensified Antiplatelet Treatment Reduces Major Cardiac Events in Patients with Clopidogrel Low Response: A Meta-analysis of Randomized Controlled Trials [J] . Lei Xu, Xiao-Wei Hu, Shu-Hua Zhang, 中华医学杂志（英文版） . 2016 ,第008期
4. Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial) [J] . Wiegel Thomas, Albers Peter, Bartkowiak Detlef, Journal of Cancer Research and Clinical Oncology . 2021 ,第1期

机译：低或早期风险前列腺癌患者治疗方式的随机试验结果（Prefere试验）
5. Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten's to the Letter to the editor Re: results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial) [J] . Wiegel Thomas, Albers Peter, Bartkowiak Detlef, Journal of Cancer Research and Clinical Oncology . 2021 ,第4期

机译：回复andreas Boehle，Frank Kahmann，Thomas Oliver Henkel，Joerg Zimmann和Stefan Machten对编辑的信Re：随机试验的患者治疗患者的治疗方式（Prefere试验）
6. Re: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial) [J] . Boehle Andreas, Kahmann Frank, Henkel Thomas Oliver, Journal of Cancer Research and Clinical Oncology . 2021 ,第4期

机译：RE：低或早期风险前列腺癌的患者治疗方式的随机试验结果（Prefere试验）
7. DO CANCER CLINICAL TRIAL POPULATIONS TRULY REPRESENT CANCER PATIENTS? A COMPARISON OF OPEN CLINICAL TRIALS TO THE CANCER GENOME ATLAS [C] . NOPHARGEIFMAN, ATUL J.BUTTE Pacific Symposium on Biocomputing . 2016

机译：癌症临床试验群体真正代表癌症患者吗？对癌症基因组阿特拉斯公开临床试验的比较
8. Exercise adherence and contamination in a randomized control trial of a home-based walking program among patients receiving active cancer treatment. [D] . Shang, Jingjing. 2009

机译：在接受主动癌症治疗的患者中，一项基于家庭步行计划的随机对照试验中的运动依从性和污染情况。
9. Effectiveness of the addition of therapeutic alliance with minimal intervention in the treatment of patients with chronic nonspecific low back pain and low risk of involvement of psychosocial factors: a study protocol for a randomized controlled trial (TalkBack trial) [O] . Felipe Ribeiro Cabral Fagundes, Caique de Melo do Espírito Santo, Francine Mendonça de Luna Teixeira, 2017

机译：增加治疗联盟并以最少的干预措施治疗慢性非特异性下背痛和社会心理因素参与风险低的患者的有效性：一项随机对照试验（TalkBack试验）的研究方案
10. Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial) [O] . Thomas Wiegel, Peter Albers, Detlef Bartkowiak, 2020

机译：低或早期风险前列腺癌患者治疗方式随机试验结果（Prefere试验）
11. Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients With High Risk Castrate, Biochemically Relapsed Prostate Cancer. [R] . Tagawa, S. T. 2017

机译：177Lu放射性标记的抗psma单克隆抗体J591在高风险阉割，生物化学复发的前列腺癌患者中的随机2期试验。

Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial) (Sep, 10.1007/s00432-020-03327-2, 2020)

摘要

著录项

相似文献

相关主题

期刊订阅